Loading...
Header Logo
Keywords
Last Name
Institution

FULIANG CHU


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chu F, Li HS, Liu X, Cao J, Ma W, Ma Y, Weng J, Zhu Z, Cheng X, Wang Z, Liu J, Jiang ZY, Luong AU, Peng W, Wang J, Balakrishnan K, Yee C, Dong C, Davis RE, Watowich SS, Neelapu SS. CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity. Leukemia. 2019 11; 33(11):2640-2653. PMID: 31028278.
      View in: PubMed
    2. Chu F, Cao J, Neelalpu SS. Versatile CAR T-cells for cancer immunotherapy. Contemp Oncol (Pozn). 2018 Mar; 22(1A):73-80. PMID: 29628798.
      View in: PubMed
    3. Mao F, Tu Q, Wang L, Chu F, Li X, Li HS, Xu W. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. Oncotarget. 2017 Jun 06; 8(23):38008-38021. PMID: 28402942.
      View in: PubMed
    4. Weng J, Moriarty KE, Baio FE, Chu F, Kim SD, He J, Jie Z, Xie X, Ma W, Qian J, Zhang L, Yang J, Yi Q, Neelapu SS, Kwak LW. IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay. Oncoimmunology. 2016; 5(12):e1237327. PMID: 28123872.
      View in: PubMed
    5. Li HS, Liu C, Xiao Y, Chu F, Liang X, Peng W, Hu J, Neelapu SS, Sun SC, Hwu P, Watowich SS. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells. Sci Signal. 2016 09 27; 9(447):ra94. PMID: 27678219.
      View in: PubMed
    6. Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46. PMID: 24771328.
      View in: PubMed
    7. Liu X, Chen X, Zhong B, Wang A, Wang X, Chu F, Nurieva RI, Yan X, Chen P, van der Flier LG, Nakatsukasa H, Neelapu SS, Chen W, Clevers H, Tian Q, Qi H, Wei L, Dong C. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature. 2014 Mar 27; 507(7493):513-8. PMID: 24463518.
      View in: PubMed
    8. Chu F, Neelapu SS. Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1+ T-cell subsets. Oncoimmunology. 2014 Jan 01; 3(1):e28101. PMID: 24808975.
      View in: PubMed
    9. Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F, Feng L, Baladandayuthapani V, Wang Z, Ma W, Gao Y, Wallace M, Vence LM, Radvanyi L, Muzzafar T, Rotem-Yehudar R, Davis RE, Neelapu SS. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol. 2014 Jan; 15(1):69-77. PMID: 24332512.
      View in: PubMed
    10. Rawal S, Chu F, Zhang M, Park HJ, Nattamai D, Kannan S, Sharma R, Delgado D, Chou T, Lin HY, Baladandayuthapani V, Luong A, Vega F, Fowler N, Dong C, Davis RE, Neelapu SS. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. J Immunol. 2013 Jun 15; 190(12):6681-93. PMID: 23686488.
      View in: PubMed
    11. Weng J, Rawal S, Chu F, Park HJ, Sharma R, Delgado DA, Fayad L, Fanale M, Romaguera J, Luong A, Kwak LW, Neelapu SS. TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. Blood. 2012 Aug 23; 120(8):1613-23. PMID: 22645177.
      View in: PubMed
    12. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, Wang YH, Lim H, Reynolds JM, Zhou XH, Fan HM, Liu ZM, Neelapu SS, Dong C. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011 Jul 24; 17(8):983-8. PMID: 21785430.
      View in: PubMed
    13. Liu J, Sun Y, Qi J, Chu F, Wu H, Gao F, Li T, Yan J, Gao GF. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis. 2010 Oct 15; 202(8):1171-80. PMID: 20831383.
      View in: PubMed
    14. Chen W, Gao F, Chu F, Zhang J, Gao GF, Xia C. Crystal structure of a bony fish beta2-microglobulin: insights into the evolutionary origin of immunoglobulin superfamily constant molecules. J Biol Chem. 2010 Jul 16; 285(29):22505-12. PMID: 20444690.
      View in: PubMed
    15. Qian X, Qi J, Chu F, Liu J, Li Q, Yan J. Crystallization and preliminary X-ray analysis of the V domain of human nectin-2. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 01; 65(Pt 6):615-7. PMID: 19478445.
      View in: PubMed
    16. Chen Y, Gao F, Chu F, Peng H, Zong L, Liu Y, Tien P, Gao GF. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes. J Mol Biol. 2009 Feb 27; 386(3):841-53. PMID: 19230061.
      View in: PubMed
    17. Ya T, Zhang Q, Chu F, Merritt J, Bilige M, Sun T, Du R, Zhang H. Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China. BMC Immunol. 2008 Nov 19; 9:68. PMID: 19019236.
      View in: PubMed
    18. Khan AH, Chu F, Feng Y, Zhang Q, Qi J, Gao GF. Crystallization and preliminary crystallographic analysis of recombinant immunoglobulin G-binding protein from Streptococcus suis. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Aug 01; 64(Pt 8):757-9. PMID: 18678951.
      View in: PubMed
    19. Chen W, Chu F, Peng H, Zhang J, Qi J, Jiang F, Xia C, Gao F. Expression, purification, crystallization and preliminary X-ray diffraction analysis of grass carp beta2-microglobulin. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Mar 01; 64(Pt 3):200-2. PMID: 18323608.
      View in: PubMed
    20. Chen Y, Chu F, Gao F, Zhou B, Gao GF. Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2). Protein Expr Purif. 2007 Dec; 56(2):253-60. PMID: 17920929.
      View in: PubMed
    21. Chu F, Lou Z, Chen YW, Liu Y, Gao B, Zong L, Khan AH, Bell JI, Rao Z, Gao GF. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape. J Immunol. 2007 Jan 15; 178(2):944-52. PMID: 17202356.
      View in: PubMed
    22. Chu F, Lou Z, Gao B, Bell JI, Rao Z, Gao GF. Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Jun 01; 61(Pt 6):614-6. PMID: 16511111.
      View in: PubMed
    23. Xu D, Zhang Z, Jin L, Chu F, Mao Y, Wang H, Liu M, Wang M, Zhang L, Gao GF, Wang FS. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis. 2005 Mar; 24(3):165-71. PMID: 15789222.
      View in: PubMed
    24. Wang FS, Chu FL, Jin L, Li YG, Zhang Z, Xu D, Shi M, Wu H, Moulds JM. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clin Exp Immunol. 2005 Jan; 139(1):112-9. PMID: 15606620.
      View in: PubMed
    25. Fan ZP, Wang FS, Xu DP, Chu FL, Shi M, Zhou Y, Zhang LX. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B]. Zhonghua Yi Xue Za Zhi. 2004 Dec 17; 84(24):2073-6. PMID: 15730619.
      View in: PubMed
    26. Xu D, Zhang Z, Chu F, Li Y, Jin L, Zhang L, Gao GF, Wang FS. Genetic variation of SARS coronavirus in Beijing Hospital. Emerg Infect Dis. 2004 May; 10(5):789-94. PMID: 15200810.
      View in: PubMed
    27. Zhang Z, Wang FS, Zhao M, Liu JC, Xu DP, Jin L, Chen JM, Wang M, Chu FL. [Characterization of peripheral dendritic cell subsets and its implication in patients infected with severe acute respiratory syndrome]. Zhonghua Yi Xue Za Zhi. 2004 Jan 02; 84(1):22-6. PMID: 14990151.
      View in: PubMed
    28. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells. Science Signaling. 9.
    29. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma. The Lancet Oncology. 15:69-77.
    30. IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay. OncoImmunology. 5.
    31. Anti-PD-1 antibodies for the treatment of B-cell lymphoma. OncoImmunology. 3.
    32. Phase II clinical trail of patients with relapsed follicular lymphoma treated with a humanized antiprogrammed death-1 monoclonal antibody combined with rituximabrreport in the 54th ASH annual meeting. Journal of Leukemia and Lymphoma. 22:77-80.
    CHU's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description